Aug 18 (Reuters) - EyePoint Pharmaceuticals Inc EYPT.O:
EYEPOINT REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.